US$ 27.82
mechanism of action for glp 1 receptor agonists of GLP-1 GLP1 Receptor Agonists—Effects beyond Obesity
Description
The review covered GLP-1s roles in controlling islet function, appetite, inflammation, and cardiovascular pathophysiology, and made a critical mechanistic distinction: native GLP-1 acts primarily via paracrine and neural mechanisms (given its 12 minute plasma half-life), whereas GLP-1RA drugs with extended half-lives act systemically on GLP-1R populations inaccessible to the native peptide

Gounder concluded: This study cant prove the drug did anything

Oral Semaglutide and Cardiovascular Outcomes in Patients With Type 2 Diabetes

By enhancing feelings of fullness, slowing stomach emptying, and supporting healthy insulin response, GLP-1 medications help you eat less and better control your weight and blood sugar
The enterogenic factor which has the function of reducing blood glucose is named enteropagin (Edgard and Jean, 2017)

GLP-1 drugs have been found applicable for various diseases such as cardiovascular disease, NASH, AD, and chronic kidney disease
